ArticleJournal of cancer research and clinical oncology2024

Comparison of neoadjuvant chemoimmunotherapy and neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a retrospective study with 3-year survival analysis.

Peiyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.